User profiles for Ayman Rezk

Ayman Rezk

University of Pennsylvania
Verified email at pennmedicine.upenn.edu
Cited by 2096

Cellular and humoral immune responses following SARS-CoV-2 mRNA vaccination in patients with multiple sclerosis on anti-CD20 therapy

…, MM Painter, RR Goel, D Mathew, K Lenzi, A Rezk… - Nature medicine, 2021 - nature.com
SARS-CoV-2 messenger RNA vaccination in healthy individuals generates immune
protection against COVID-19. However, little is known about SARS-CoV-2 mRNA vaccine-induced …

Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy

R Li, A Rezk, Y Miyazaki, E Hilgenberg… - Science translational …, 2015 - science.org
B cells are not limited to producing protective antibodies; they also perform additional
functions relevant to both health and disease. However, the relative contribution of functionally …

MerTK is a functional regulator of myelin phagocytosis by human myeloid cells

…, SY Won, MA Michell-Robinson, A Rezk… - The Journal of …, 2016 - journals.aai.org
Multifocal inflammatory lesions featuring destruction of lipid-rich myelin are pathologic hallmarks
of multiple sclerosis. Lesion activity is assessed by the extent and composition of myelin …

Human mesenchymal stem cells impact Th17 and Th1 responses through a prostaglandin E2 and myeloid-dependent mechanism

A Rozenberg, A Rezk, MN Boivin… - Stem cells …, 2016 - academic.oup.com
Human mesenchymal stem cells (hMSCs) are being increasingly pursued as potential
therapies for immune-mediated conditions, including multiple sclerosis. Although they can …

Cytokine-defined B cell responses as therapeutic targets in multiple sclerosis

R Li, A Rezk, LM Healy, G Muirhead, A Prat… - Frontiers in …, 2016 - frontiersin.org
Important antibody-independent pathogenic roles of B cells are emerging in autoimmune
diseases, including multiple sclerosis (MS). The contrasting results of different treatments …

Dimethyl fumarate treatment mediates an anti-inflammatory shift in B cell subsets of patients with multiple sclerosis

R Li, A Rezk, M Ghadiri, F Luessi, F Zipp… - The Journal of …, 2017 - journals.aai.org
The therapeutic mode of action of dimethyl fumarate (DMF), approved for treating patients
with relapsing-remitting multiple sclerosis, is not fully understood. Recently, we and others …

Transcription factor Nr4a1 couples sympathetic and inflammatory cues in CNS-recruited macrophages to limit neuroinflammation

…, GD Thomas, S Lai-Wing-Sun, A Rezk… - Nature …, 2015 - nature.com
The molecular mechanisms that link the sympathetic stress response and inflammation
remain obscure. Here we found that the transcription factor Nr4a1 regulated the production of …

Dimethyl fumarate–induced lymphopenia in MS due to differential T-cell subset apoptosis

M Ghadiri, A Rezk, R Li, A Evans, F Luessi… - Neurology …, 2017 - AAN Enterprises
Objective: To examine the mechanism underlying the preferential CD8 + vs CD4 + T-cell
lymphopenia induced by dimethyl fumarate (DMF) treatment of MS. Methods: Total lymphocyte …

Differential effects of anti-CD20 therapy on CD4 and CD8 T cells and implication of CD20-expressing CD8 T cells in MS disease activity

K Shinoda, R Li, A Rezk, I Mexhitaj… - Proceedings of the …, 2023 - National Acad Sciences
A small proportion of multiple sclerosis (MS) patients develop new disease activity soon
after starting anti-CD20 therapy. This activity does not recur with further dosing, possibly …

Charging and discharging characteristics of a single gold nanoparticle embedded in Al2O3 thin films

A Rezk, Y Abbas, I Saadat, A Nayfeh… - Applied Physics …, 2020 - pubs.aip.org
We demonstrate a metal-oxide-semiconductor based nonvolatile memory element structure
with a single isolated gold nanoparticle (Au-NP) acting as the storage site. The Au-NPs are …